120 related articles for article (PubMed ID: 8931688)
1. Commentary on "Adequacy of chemotherapy prior to cytoreductive surgery in testicular carcinoma" by B. J. Kennedy, Jane L. Torkelson, and Elwin E. Fraley in this issue pp. 541-545.
Kagan AR
Am J Clin Oncol; 1996 Dec; 19(6):636. PubMed ID: 8931688
[No Abstract] [Full Text] [Related]
2. Adequacy of chemotherapy prior to cytoreductive surgery in testicular carcinoma.
Kennedy BJ; Torkelson JL; Fraley EE
Am J Clin Oncol; 1996 Dec; 19(6):541-5. PubMed ID: 8931667
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for testicular cancer.
Xiao H; Sheinfeld J; Motzer RJ
Surg Oncol Clin N Am; 1997 Oct; 6(4):863-78. PubMed ID: 9309098
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
[TBL] [Abstract][Full Text] [Related]
5. Optimal number of chemotherapy courses in advanced nonseminomatous testicular carcinoma.
Kennedy BJ; Torkelson J; Fraley EE
Am J Clin Oncol; 1995 Dec; 18(6):463-8. PubMed ID: 8526185
[TBL] [Abstract][Full Text] [Related]
6. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
7. [Critical analysis of the efficacy and toxicity of current chemotherapy in advanced non-seminoma testicular cancer: 3 years' experience].
Germa Lluch JR; Marcuello Gaspar E; Badía Canto A; Dorca Ribugent J; Oltra Juste I; Arcusa Lanza A; Gallén Castillo M; Mila López JA
Actas Urol Esp; 1984; 8(1):53-8. PubMed ID: 6202110
[No Abstract] [Full Text] [Related]
8. Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy.
Gelderman WA; Schraffordt Koops H; Sleijfer DT; Oosterhuis JW; Van der Heide JN; Mulder NH; Marrink J; De Bruyn HW; Oldhoff J
J Surg Oncol; 1988 Aug; 38(4):227-32. PubMed ID: 2457771
[TBL] [Abstract][Full Text] [Related]
9. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of the treatment with chemotherapy and surgery in patients with advanced testicular cancer].
Tsukamoto T; Kumamoto Y; Omura K; Miyao N; Yamazaki K; Iwasawa A; Hirose T
Nihon Hinyokika Gakkai Zasshi; 1988 Sep; 79(9):1516-23. PubMed ID: 2468806
[No Abstract] [Full Text] [Related]
11. Treatment of childhood Hodgkin's disease with ABVD without radiotherapy.
Behrendt H; Brinkhuis M; Van Leeuwen EF
Med Pediatr Oncol; 1996 Apr; 26(4):244-8. PubMed ID: 8600335
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of disseminated testicular cancer.
Einhorn LH
Acta Urol Belg; 1985; 53(2):411-27. PubMed ID: 2409784
[No Abstract] [Full Text] [Related]
13. [Characteristics of the growth and regression of metastases of malignant testicular tumors to the lungs during chemotherapy].
Lichinitser MR; Vetrova NA; Tikhonina AM; Spiridonova TA
Vopr Onkol; 1989; 35(4):482-4. PubMed ID: 2471356
[No Abstract] [Full Text] [Related]
14. [Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy].
Riedinger JM; Eche N; Chevreau C; Fargeot P
Ann Biol Clin (Paris); 2008; 66(5):523-30. PubMed ID: 18957341
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients with viable malignant non-seminomatous germ cell tumour persistent after cisplatin-based induction chemotherapy.
Hollender A; Stenwig EA; Ous S; Fosså SD
Eur Urol; 1997; 31(2):141-7. PubMed ID: 9076455
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
17. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
Pectasides D; Mylonakis A; Kostopoulou M; Papadopoulou M; Triantafillis D; Varthalitis J; Dimitriades M; Athanassiou A
Am J Clin Oncol; 1997 Aug; 20(4):348-53. PubMed ID: 9256887
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of testicular carcinomas.
Monfardini S
Anticancer Res; 1981; 1(6):309-12. PubMed ID: 6178356
[No Abstract] [Full Text] [Related]
19. Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.
Stoter G; Koopman A; Vendrik CP; Struyvenberg A; Sleyfer DT; Willemse PH; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
J Clin Oncol; 1989 Aug; 7(8):1099-104. PubMed ID: 2474060
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for good-risk germ-cell tumors.
Ryan CJ; Bajorin DF
Semin Urol Oncol; 2002 Nov; 20(4):244-50. PubMed ID: 12489057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
